environmental

Havana (VNA) – The Finlay Vaccine Institute (IFV) of Cuba and the Vietnamese company Vabiotech agreed this Friday in Havana to strengthen ties in the field of biotechnology.

“A delegation from the Vietnamese company Vabiotech, led by its director, Nguyen Anh Tuan, visited the IFV. There was discussion about joint collaboration and future projects. The representatives of Vietnam received an update on the work of the Institution,” states a message from the Caribbean entity on the social network X.

“In the exchange between IFV and the Vietnamese company Vabiotech, the desire to continue expanding the links of collaboration between both biotechnology institutions was expressed,” the text underlines.

Vabiotech is one of the leading companies in Vietnam in the manufacturing, marketing, research and development of a wide range of vaccines, diagnostic kits, biological, therapeutic, and pharmaceutical products; cosmetics, food, in addition to the provision of health services.

Currently, Vabiotech produces four vaccines: Hepatitis B, Hepatitis A, Japanese Encephalitis and Oral Cholera, and also imports immunogens to combat mumps, rubella, meningococcus and chickenpox.

The IFV of Cuba has glycoconjugated, synthetic, combined, therapeutic and infectious disease injectables. The effects of these products in the control of epidemics such as the one caused by Neisseria meningitidis in 1989 in Cuba and was eradicated with the VA-MENGOC-BC are recognized.

A trivalent anti-leptospirosis vaccine was also obtained from inactivated cells of Lectospira interrogans (serovars Canicola canicola, Pomona mozdok and Icterohaemorrhagiae copenhageni) to combat outbreaks of leptospirosis, among other scientific achievements that largely guarantee the sovereignty of the nation in this field.

Previously, the Duc Minh Medical Joint Stock Company (Almedic) of Vietnam also signed supply agreements in Hanoi with the Center for Genetic Engineering and Biotechnology (CIGB) and the Center for Molecular Immunology (CIM), both Cuban.

Under the contracts, which are part of the cooperation and trade plan between Almedic and its partners in 2024, in addition to vaccines, CIMAher (a monoclonal antibody to treat head and neck, pancreatic and esophageal cancer) and the CIMVAx EGF (for treatment of lung cancer).

Almedic also cooperates with the Pasteur Da Lat vaccine company to produce a stage of Cuban vaccines in Vietnam and coordinates the sending of Vietnamese technicians and managers to biology centers and advanced laboratories in Cuba for short-term studies and training, as well as for bring Cuban experts to Vietnam to provide advice and training./.

2023-11-25 09:34:00
#Vietnam #Cuba #strengthen #ties #biotechnology #Vietnam

Illustration photo. (Source: baodautu.vn) Hanoi (VNA) – Vietnam is one of the countries that will participate in the tests of the Japanese vaccine against dengue, revealed Nguyen Van Kinh, vice president of the Vietnam Medical Association.

According to the official, to have a thorough evaluation of the impact of the vaccine, it is necessary to carry out tests before applying it widely in the community.

According to the Ministry of Health, from the beginning of the year until now, the country has registered more than 90 thousand cases of dengue, of which 26 are fatal.

Hanoi is one of the “hot” points in the country as the number of dengue cases continues to increase. In the first week of October, the Vietnamese capital reported almost 2,600 victims of the febrile illness, bringing the number of patients in this regard so far this year to almost 18,000.

Previously, some countries tested and licensed a vaccine to prevent dengue, but the effectiveness was not as expected, especially with dengue type 2 virus, which is the most popular today.

Recently, Japan produced an antiviral substance intended for both adults and children to prevent the disease, and the initial test showed its effectiveness in preventing the 4 types of dengue viruses.

According to the World Health Organization (WHO), febrile illness is classified as one of the 10 global health challenges, and up to 40% of the world’s population lives in areas at risk of dengue hemorrhagic fever infection.

It is estimated that dengue causes around 20 thousand deaths worldwide each year.

Treatment of dengue patients at Bach Mai Hospital, Hanoi. (Source: hanoimoi.com.vn)

The disease is caused by four serotypes of the dengue virus (DEN-1, DEN-2, DEN-3, DEN-4), of which DEN-1 and DEN-2 account for 90% of cases.

In particular, a second dengue infection is very dangerous because the condition is usually more serious than the first./.

2023-10-13 03:22:00
#Vietnam #participate #trials #Japanese #dengue #vaccine #Vietnam

Vaccination for children in Vietnam (Source: VNA) Hanoi (VNA) The National Institute of Hygiene and Epidemiology decided to allocate 185 thousand doses of the DPT-VGB-Hib vaccine to 49 cities and provinces within this month.

The vaccine helps protect children against diphtheria, pertussis, tetanus, hepatitis B, and haemophilus influenzae type b (Hib).

The doses are part of a batch of the vaccine financed by the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF), which arrived in Hanoi on July 27 to serve the expanded national program of immunization.

Previously, 72,300 doses were distributed to 14 northern mountainous provinces, using national funds.

Like other countries around the world, routine immunization services in Vietnam were disrupted during the COVID-19 pandemic, resulting in some 114,000 children under one year of age not receiving vaccinations against diphtheria, tetanus and pertussis, which are used as indicators of global immunization coverage, in 2022.

Furthermore, due to the recent shortage of the 5-in-1 vaccine, an estimated 300,000 Vietnamese children born in early 2023 have yet to receive this essential vaccine.

The WHO representative in Vietnam, Angela Pratt, said the organization will continue to work with UNICEF and other partners to support the Vietnamese government, ensuring that all children in all corners of the country receive full and timely vaccinations, both now and in the future. future./.

VNA

2023-08-16 03:28:00
#doses #5in1 #vaccine #distributed #locations #month #Vietnam

Hanoi (VNA) – Vietnamese Vice Premier Tran Hong Ha stressed the need to strengthen cooperation on vaccines and biopharmaceuticals to proactively prevent and control diseases, hosting AstraZeneca Vietnam Chairman and CEO Nitin Kapoor in Hanoi today. .

The Subhead thanked AstraZeneca for its valuable and timely support to Vietnam in the fight against COVID-19.

He expressed his impression of AstraZeneca’s ongoing collaborative activities in Vietnam, particularly in the fields of vaccines and biopharmaceuticals, saying that this plays a crucial role in proactively preparing for potential disease outbreaks in the future.

Vietnam supports AstraZeneca’s commitments to reduce emissions and move towards carbon neutrality in all its activities, Hong Ha said, stressing that the experience in preventing and controlling COVID-19 showed that the world can only roll back and end the pandemic if all countries have equal access to vaccines.

Similarly, the goals related to addressing climate change and reducing greenhouse gas emissions cannot be achieved if there are countries that remain “on the sidelines” of these efforts, he said.

He highlighted the close relationship between human health and the “health” of the environment, stating that restoring and protecting the natural environment is a crucial solution to prevent and reduce the burden of disease-related costs on individuals and society due to to water, air and waste pollution.

The technology is a “vaccine” to tackle climate change, Ha noted, adding that developing countries like Vietnam need a lot of support and access to various solutions to reduce greenhouse gas emissions.

Companies with strong research and development capabilities like AstraZeneca play a crucial role in achieving climate change goals, such as reducing emissions to net zero and participating in the Just Energy Transition Partnership (JETP) by joining projects to research and transfer green fuel production technologies, and develop smart transmission systems and large-scale energy storage devices, he said.

Mentioning AstraZeneca’s project to plant 22.5 million trees, the Deputy Prime Minister assigned the Ministry of Agriculture and Rural Development (MARD) and the Climate Change Department of the Ministry of Natural Resources and Environment to work closely with AstraZeneca to carry out the project effectively.

He expressed his hope that AstraZeneca would participate in projects related to the Net Zero Roadmap and JETP in Vietnam, which serve as experimental and pilot initiatives for global mechanisms.

Vietnamese Vice Prime Minister Tran Hong Ha receives AstraZeneca Vietnam Chairman and CEO Nitin Kapoor. (Source: VNA) For his part, Nitin Kapoor briefed the Deputy Prime Minister on various collaborative programs and projects currently underway in Vietnam to strengthen patient access to medicines, develop a sustainable healthcare system, improve public health and Conduct clinical trials of drugs and biopharmaceuticals.

AstraZeneca is collaborating with Vietnamese agencies and partners to implement a $50 million reforestation and landscape restoration project, which aims to plant 22.5 million trees on 30,500 ha, thereby creating the conditions for development of biodiversity and providing sustainable livelihoods for more than 17,000 households, Kapoor said.

He expressed his hope that the project will serve as a pilot initiative in the National Steering Committee’s action plan to implement Vietnam’s commitments at the 26th UN Climate Change Conference of the Parties (COP26), so encourages other organizations and companies to take joint measures to respond to this phenomenon of global impact./.

2023-08-14 09:00:00
#Promote #cooperation #vaccines #disease #prevention #Vietnam